Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Total Current Liabilities (2016 - 2025)

Nephros has reported Total Current Liabilities over the past 16 years, most recently at $2.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $2.8 million for Q4 2025, up 77.14% from a year ago — trailing twelve months through Dec 2025 was $2.8 million (up 77.14% YoY), and the annual figure for FY2025 was $2.8 million, up 77.14%.
  • Total Current Liabilities for Q4 2025 was $2.8 million at Nephros, up from $2.5 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for NEPH hit a ceiling of $2.8 million in Q4 2025 and a floor of $1.1 million in Q3 2024.
  • Median Total Current Liabilities over the past 5 years was $1.8 million (2021), compared with a mean of $1.8 million.
  • Biggest five-year swings in Total Current Liabilities: crashed 54.7% in 2021 and later skyrocketed 133.18% in 2025.
  • Nephros' Total Current Liabilities stood at $2.4 million in 2021, then crashed by 40.92% to $1.4 million in 2022, then surged by 49.65% to $2.1 million in 2023, then fell by 26.08% to $1.6 million in 2024, then surged by 77.14% to $2.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $2.8 million (Q4 2025), $2.5 million (Q3 2025), and $1.8 million (Q2 2025) per Business Quant data.